38 results on '"Wacher, N"'
Search Results
2. Internal Targeted Hypothermia Versus Normothermia After Cardiac Arrest: Systematic Review and Meta-analysis, an Update
- Author
-
Moreno, Y.B., primary, Marcano, C.B., additional, Wacher, N., additional, and Hernandez, F., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Effect of Haloperidol on Mortality, Number of Adverse Effects and Length of Stay Among Patients in the Intensive Care Unit: An Updated Systematic Review and Meta-analysis
- Author
-
Marcano, C.B., primary, Moreno, Y.B., additional, Wacher, N., additional, and Kosseifi, S., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas
- Author
-
Parra, E. J., Below, J. E., Krithika, S., Valladares, A., Barta, J. L., Cox, N. J., Hanis, C. L., Wacher, N., Garcia-Mena, J., Hu, P., Shriver, M. D., Kumate, J., McKeigue, P. M., Escobedo, J., Cruz, M., and Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium
- Published
- 2011
- Full Text
- View/download PDF
5. Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with Type 2 diabetes
- Author
-
Cruz, M., Maldonado-Bernal, C., Mondragón-Gonzalez, R., Sanchez-Barrera, R., Wacher, N. H., Carvajal-Sandoval, G., and Kumate, J.
- Published
- 2008
- Full Text
- View/download PDF
6. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study
- Author
-
Guerrero-Romero, F., Rascón-Pacheco, R. A., Rodríguez-Morán, M., de la Peña, J. Escobedo, and Wacher, N.
- Published
- 2008
7. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City
- Author
-
Parra, E J, Cameron, E, Simmonds, L, Valladares, A, McKeigue, P, Shriver, M, Wacher, N, Kumate, J, Kittles, R, and Cruz, M
- Published
- 2007
8. MGEA5-14 polymorphism and type 2 diabetes in Mexico city
- Author
-
Cameron, E.A., Martinez-Marignac, V.L., Chan, A., Valladares, A., Simmonds, L.V., Wacher, N., Kumate, J., McKeigue, P., Shriver, M.D., Kittles, R., Cruz, M., and Parra, E.J.
- Subjects
Type 2 diabetes -- Genetic aspects ,Type 2 diabetes -- Risk factors ,Genetic polymorphisms -- Analysis ,Biological sciences - Abstract
The distribution of gene MGEA5 SNP in a sample of Type 2 Diabetes patients is evaluated. This analysis of the parental samples provides the information regarding the distribution of the MGEA5-14 polymorphism and its potential impact on diabetes risk.
- Published
- 2007
9. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- Author
-
James, Wp, Caterson, Id, Coutinho, W, Finer, N, VAN GAAL LF, Maggioni, Ap, TORP-PEDERSEN, C, Sharma, Am, Shepherd, Gm, Rode, Ra, Renz, Cl, Van Gaal LF, Torp-Pedersen, C, Pepine, C, Pocock, S, Drexler, H, Swedberg, K, Sleight, P, Armstrong, P, Kerr, D, Dagenais, G, Brophy, J, Avezum, A, Bogaty, P, Fabbri, G, Galli, M, Hildebrandt, P, Mann, J, Ostergren, J, Sherman, D, Zannad, F, Colquhoun, D, Hollanders, G, e Forti A, Costa, Cifkova, R, Toubro, S, Ziegler, O, Scherbaum, Wa, Jordan, J, Halmy, L, Ferrannini, E, Santini, F, Gonzalez, C, Narkiewicz, K, Hancu, N, Payer, J, Pascual, J, Wilding, J, Campbell, L, Carey, D, Gerstman, M, Karrasch, J, Lefkovits, J, Marks, J, Marks, S, Moses, R, Phillips, P, Proietto, J, Roberts, D, Roberts-Thomson, P, Shaw, J, Simpson, R, Singh, B, Singleton Jeffries, W, Stuckey, B, Boland, J, Brohet, C, Coucke, F, Dendale, P, Jouret, G, Kolanowski, J, Kutnowski, M, Martens, F, Muls, E, Peiffer, F, Penninckx, H, Scheen, A, Schoors, D, Vaerenberg, M, Van Cleemput, J, Van Crombrugge, P, Van Kuyk, M, Verhaegen, A, Wollaert, B, de Albuquerque DC, Appolinario, J, de Godoy Matos AF, Gross, Jl, Halpern, A, Kerr Saraiva JF, Milagres, R, Repetto, G, Suplicy, Hl, Zanella, Mt, Bednarova, J, Cepelak, V, Cerny, P, Hainer, V, Havranek, P, Homza, M, Jansa, P, Karlicek, M, Kolesar, J, Kotik, I, Kucera, D, Kuchar, J, Kunc, M, Kvapil, M, Linhart, A, Machova, V, Matuska, J, Oral, I, Pavlas, J, Pesatova, S, Povolny, J, Semrad, B, Smetana, K, Soucek, M, Svacina, S, Tesinsky, P, Urbanek, R, Wasserburger, B, Zachoval, R, Zahumensky, E, Zidkova, E, Astrup, A, Dominguez, H, Faber, J, Hilderbrant, P, Kober, L, Perrild, H, Richelsen, B, Sogaard, P, Svendsen, Ol, Urhammer, S, Archambeaud, F, Basdevant, A, Borys, Jm, Bringer, J, Brunetiere, C, Charpentier, G, Cocaul-André, M, Dabadie, H, Dubreuil, A, Estour, B, Gautier, Jf, Gibault, T, Halimi, S, Hespel, Jp, Issa Sayegh, M, Krempf, M, Laville, M, Lecerf, Jm, Louvet, Jp, Penfornis, A, Ritz, P, Schlienger, Jl, Schmitt, B, Valensi, P, Baar, M, Beermann, J, Bock, M, Boenner, G, Dammann, Hg, Diehm, C, Ditschuneit, H, Gadow, J, Gehlhar, S, Gessner, S, Guthersohn, A, Hamann, A, Hanefeld, M, Hasenfuss, G, Herzner, A, Heun, Kc, Heufelder, Ae, Hohensee, H, Jacob, S, Krings, P, Krätzig, B, Krosse, B, Lehmann, Rt, Mindt-Prüfert, S, Maisch, B, Pfeiffer, Af, Richard, F, Rose, B, Schmidt, E, Scholze, J, Schreckenberg, A, Stuebler, P, Walter, J, Wirth, A, Wunderlich, J, Abraham, G, Altorjay, A, Augusztin, G, Csaszar, A, Czuriga, I, Dinnyes, J, Gero, L, Gyimesi, A, Janosi, A, Kovacs, I, Liziczai, I, Majtenyi, A, Medvegy, M, Nadhazi, Z, Pados, G, Polak, G, Ronaszeki, A, Sido, Z, Simon, K, Anzà, C, Bevilacqua, M, Bosello, O, Chiariello, M, Cordera, R, Ferrari, E, Frittitta, L, Giorgino, R, Liuzzi, A, Malinverni, C, Di Mario, U, Melchionda, N, Occhi, G, Perticone, F, Pinchera, A, Pinelli, G, Rovera, G, Santeusanio, F, Urbinati, S, Alpizar-Salazar, M, Carrillo-Ortega, E, Fanghanel Salmon, G, Laviada-Molina, Ha, Madero, Ma, Rodriguez, G, Saldate, C, Sanchez-Castillo, Cp, Violante, Rm, Wacher, N, Zayas-Jaime, Fj, Zuniga-Guajardo, S, Adamiec, R, Banasiak, W, Chrusciel, P, Derlaga, B, Gebala, A, Gessek, J, Janik, K, Janion, M, Kalina, Z, Kozlowski, A, Kusnierz, B, Majcher, Z, Miekus, P, Niegowska, J, Okopien, B, Ostrowska, L, Pasowicz, M, Piepiorka, M, Pluta, W, Polaszewska-Muszynska, M, Ponikowski, P, Pupek-Musialik, D, Sawicki, A, Sobocik, H, Stankiewicz, A, Szpajer, M, Trojnar, R, Tykarski, A, Wrabec, K, Wyrzkowski, B, Zahorska-Markiewicz, B, Zalewski, M, Carrageta, M, Mendes Pedro MM, Parente Martins LM, dos Santos, L, Babes, A, Creteanu, G, Dan, Ga, Dragulescu, Si, Graur, M, Tirgoviste, Ci, Morosanu, M, Mota, M, Paveliu, Fs, Radoi, M, Ranetti, A, Totoian, I, Andre, I, Bugan, V, Cencarik, J, Csala, L, Farsky, S, Gonsorcik, J, Kamensky, G, Kmec, J, Krahulec, B, Kurian, R, Macek, V, Majercak, I, Micko, K, Mokan, M, Riecansky, I, Sojka, G, Uhliar, R, Urgeova, L, Vancik, J, Baro, Fm, Barrios Merino, A, Borras, Jl, Caixas, A, Cuatrecasas Cambra, G, Dominguez Escribano JR, Duran Garcia, S, Escobar-Jimenez, L, Esteva de Antonio, I, Formiguera Sala, X, Garcia-Luna, Pp, Garcia Robles, R, Gonzalez Albarran, O, Hernandez-Mijares, A, Martin Hidalgo, A, Masmiquel Comas, L, Morales Perez, F, Moreno Esteban, B, Pascual Izuel JM, Redon Mas, J, Ricart, W, Rubio, Ma, Ruilope, Lm, Salas-Salvado, J, Terroba Larumbe, M, Tinahones, F, de la Torre Casares ML, Vidal Cortada, J, Zuniga-Perez Lemaur, M, Abdulhakim, Ee, Adler, A, Barnett, Ah, Bodmer, C, Campbell, Iw, Chowdhury, T, Cleland, J, Cook, Rc, Dinneen, S, Donnachie, H, Haslam, Dw, Hillis, Gs, Horne, M, Howarth, Dj, Hughes, E, Jackson, S, Jones, Sc, Jones, Th, Kumar, S, Lean, M, Maroni, J, Mcinnes, G, Middleton, A, Morris, A, Newcombe, G, O'Kane, Kp, Pavel, Ic, Pawa, R, Perry, C, Pitts, C, Raja, A, Reckless, J, Robinson, J, Sarmiento, R, Soo, Sc, Taylor, S, Thomas, Ho, Thomson, Ma, and Wilkins, M.
- Subjects
Male ,medicine.medical_specialty ,Myocardial Infarction ,Blood Pressure ,Kaplan-Meier Estimate ,Type 2 diabetes ,Klinikai orvostudományok ,Placebo ,law.invention ,Double-Blind Method ,Randomized controlled trial ,Weight loss ,law ,Internal medicine ,Appetite Depressants ,medicine ,Humans ,Obesity ,Myocardial infarction ,Stroke ,Aged ,business.industry ,Hazard ratio ,Orvostudományok ,General Medicine ,Middle Aged ,Overweight ,medicine.disease ,Surgery ,Diabetes Mellitus, Type 2 ,Cardiovascular Diseases ,Cardiology ,Female ,Human medicine ,medicine.symptom ,business ,Cyclobutanes ,Sibutramine ,medicine.drug - Abstract
Background The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established. Methods We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older, with preexisting cardiovascular disease, type 2 diabetes mellitus, or both to assess the cardiovascular consequences of weight management with and without sibutramine in subjects at high risk for cardiovascular events. All the subjects received sibutramine in addition to participating in a weight-management program during a 6-week, single-blind, lead-in period, after which 9804 subjects underwent random assignment in a double-blind fashion to sibutramine (4906 subjects) or placebo (4898 subjects). The primary end point was the time from randomization to the first occurrence of a primary outcome event (nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, or cardiovascular death). Results The mean duration of treatment was 3.4 years. The mean weight loss during the lead-in period was 2.6 kg; after randomization, the subjects in the sibutramine group achieved and maintained further weight reduction (mean, 1.7 kg). The mean blood pressure decreased in both groups, with greater reductions in the placebo group than in the sibutramine group (mean difference, 1.2/1.4 mm Hg). The risk of a primary outcome event was 11.4% in the sibutramine group as compared with 10.0% in the placebo group (hazard ratio, 1.16; 95% confidence interval [CI], 1.03 to 1.31; P=0.02). The rates of nonfatal myocardial infarction and nonfatal stroke were 4.1% and 2.6% in the sibutramine group and 3.2% and 1.9% in the placebo group, respectively (hazard ratio for nonfatal myocardial infarction, 1.28; 95% CI, 1.04 to 1.57; P=0.02; hazard ratio for nonfatal stroke, 1.36; 95% CI, 1.04 to 1.77; P=0.03). The rates of cardiovascular death and death from any cause were not increased. Conclusions Subjects with preexisting cardiovascular conditions who were receiving long-term sibutramine treatment had an increased risk of nonfatal myocardial infarction and nonfatal stroke but not of cardiovascular death or death from any cause. (Funded by Abbott; ClinicalTrials.gov number, NCT00234832.)
- Published
- 2010
10. Insulin resistance in offspring of hypertensive subjects
- Author
-
Gordon F, M. E. Fonseca, Dolores Mino, Lifshitz A, Revilla C, Wacher N, Búrbano G, and Amato D
- Subjects
Adult ,Male ,medicine.medical_specialty ,Physiology ,Offspring ,medicine.medical_treatment ,Blood Pressure ,Insulin resistance ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Obesity ,Family history ,Pancreatic hormone ,Aged ,Family Health ,business.industry ,Insulin ,Middle Aged ,medicine.disease ,Logistic Models ,Endocrinology ,Blood pressure ,Socioeconomic Factors ,Hypertension ,Female ,Insulin Resistance ,Cardiology and Cardiovascular Medicine ,business ,Body mass index - Abstract
OBJECTIVE To assess whether apparently healthy subjects with a family history of systemic hypertension have a higher risk of presenting the insulin resistance syndrome. SUBJECTS Three hundred and eighty-six subjects aged 20-65 years. SETTING A middle socio-economic class urban community from Mexico City. METHOD All subjects and, when necessary, their first-degree relatives, answered a questionnaire and underwent a physical examination with measurement of height, weight and blood pressure. Serum insulin, glucose, cholesterol and triglycerides were measured during fasting and 2 h after an oral load of 75 g glucose. RESULTS A family history of systemic hypertension was present for 167 (43%) of the subjects, of whom 123 (31%) were obese. Subjects with a family history of hypertension had higher systolic blood pressures than did those without such a history (120 +/- 15 versus 115 +/- 10 mmHg). In the logistic regression model, the body mass index and age showed statistically significant effects on the fasting glucose:insulin ratio and on serum insulin levels after an oral load of glucose. When men and women were analysed separately, only in men were higher systolic and mean blood pressures and lower glucose:insulin ratios observed. In the logistic regression analysis the body mass index was a significant predictor of the glucose:insulin ratio and serum insulin levels after an oral load of glucose, especially in men. CONCLUSION Apparently healthy male offspring of hypertensive parents have higher blood pressure levels and lower insulin sensitivities than do offspring of normotensive parents. Insulin resistance was related to obesity, but not to a family history of hypertension, as had previously been reported by other research groups.
- Published
- 1996
11. The Use of Complementary and Alternative Medicine Therapies in Type 2 Diabetic Patients in Mexico
- Author
-
Argaez-Lopez, N., primary, Wacher, N. H., additional, Kumate-Rodriguez, J., additional, Cruz, M., additional, Talavera, J., additional, Rivera-Arce, E., additional, and Lozoya, X., additional
- Published
- 2003
- Full Text
- View/download PDF
12. Insulin resistance in offspring of hypertensive subjects.
- Author
-
Mino D, Wacher N, Amato D, Búrbano G, Fonseca ME, Revilla C, Gordon F, Lifshitz A, Mino, D, Wacher, N, Amato, D, Búrbano, G, Fonseca, M E, Revilla, C, Gordon, F, and Lifshitz, A
- Published
- 1996
- Full Text
- View/download PDF
13. Pentoxifylline and oxygen consumption in severe sepsis ‐ A preliminary report
- Author
-
CASTAÑON‐GONZALEZ, J. A., primary, EID‐LIDT, G., additional, WACHER, N., additional, GALLEGOS‐PEREZ, H., additional, and MIRANDA‐RUIZ, R., additional
- Published
- 1995
- Full Text
- View/download PDF
14. A Rating System for Prompt Clinical Diagnosis of Ischemic Stroke
- Author
-
Talavera, J. O., Wacher, N. H., Laredo, F., Lopez, A., Martinez, V., Gonzalez, J., Lifshitz, A., and Feinstein, A. R.
- Published
- 2000
- Full Text
- View/download PDF
15. Level of expression of gene CTSL and its correlation with natural killer T-cells in Mexican pediatric patients with recent-onset type 1 diabetes,Asociación de células NKT con la expresión del gen CTSL en población pediátrica Mexicana con diabetes tipo 1 de reciente diagnostic
- Author
-
Gómez-Díaz, R. A., Medina-Santillán, R., Castro-Magdonel, B. E., Bekker-Méndez, C., Gómez-Zamudio, J., Nishimura-Meguro, E., Garrido-Magaña, E., Lizárraga-Paulin, L., Aguilar-Herrera, B. E., Valladares-Salgado, A., Miguel Cruz Lopez, Mondragón-González, R., Ortiz-Navarrete, V., and Wacher, N. H.
16. HLA Risk Haplotype: Insulin Deficiency in Pediatric Type 1 Diabetes
- Author
-
rita gomez-diaz, Nishimura-Meguro, E., Garrido-Magaña, E., Lizárraga-Paulin, L., Aguilar-Herrera, B. E., Bekker-Méndez, C., Medina-Santillán, R., Barquera, R., Mondragón-González, R., and Wacher, N. H.
17. Triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index as a reference criterion of risk for metabolic syndrome (MetS) and low insulin sensitivity in apparently healthy subjects,Índice de triglicéridos/lipoproteína de alta densidad unida a colesterol (TG/HDL-C) como criterio de riesgo para síndrome metabólico (SMet) y baja sensibilidad a la insulina en sujetos aparentemente sanos
- Author
-
Blanca Guadalupe Baez Duarte, Zamora-Gínez, I., González-Duarte, R., Torres-Rasgado, E., Ruiz-Vivanco, G., Pérez-Fuentes, R., Guerrero-Romero, F., Rodriguez-Moran, M., La Pena, J. E., Wacher, N., Chavez-Negrete, A., Revilla-Monsalve, C., Martinez-Abundis, E., Garcia Alba, J. E., Gonzalez-Ortiz, M., and Islas-Andrade, S.
18. Poor metabolic control in primary care,Causas de descontrol metabólico en atención primaria
- Author
-
Wacher, N. H., Silva, M., Valdez, L., Cruz, M., and rita gomez-diaz
19. Association of v249i and t280m variants of fractalkine receptor cx3cr1 with carotid intima-media thickness in a mexican population with type 2 diabetes
- Author
-
rita gomez-diaz, Gutiérrez, J., Contreras-Rodriguez, A., Valladares-Salgado, A., Tanus-Hajj, J., Mondragón-González, R., Talavera, J. O., Mejía-Benitez, M. A., García-Mena, J., Cruz, M., and Wacher, N. H.
20. Carotid Intima-Media Thickness, Ankle-Arm Index, and Inflammation Profile in Mexican Patients with Early and Late Onset Type 2 Diabetes
- Author
-
Contreras-Rodríguez, A., rita gomez-diaz, Tanus-Hajj, J., Talavera, J. O., Mondragón-González, R., and Wacher, N. H.
21. Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA.
- Author
-
Alemán-Contreras R, Gómez-Díaz RA, Noyola-García ME, Mondragón-González R, Wacher N, and Ferreira-Hermosillo A
- Abstract
Background: The prevalence of obesity has increased in patients with type 1 diabetes (T1D) and latent autoimmune diabetes of the adult (LADA), limiting the use of clinical features such as the body mass index for its differentiation with type 2 diabetes (T2D). Additionally, some patients with maturity-onset diabetes of the young (MODY) or LADA are misdiagnosed as having T2D. The evaluation of autoantibodies and genetic testing are not fully available. We aimed to evaluate the utility of a widely available and less expensive diagnostic tool such as C-peptide to differentiate between T1D, T2D, MODY, and LADA., Methods: Our study included 38 patients with T1D, 49 with T2D, 13 with MODY, and 61 with LADA. We recorded anthropometric measurements, biochemical profiles, and antidiabetic treatment and determined C-peptide, anti-GAD65, and anti-IA2 antibodies., Results: C-peptide concentration differed significantly among populations (T1D: 0.2 ng/mL; T2D: 2.4 ng/mL; MODY: 1.14 ng/mL; LADA: 1.87 ng/mL). Through a ROC curve, we observed that the C-peptide cut-off point of 0.95 ng/mL allows differentiation between T1D and T2D (sensitivity 82%, specificity 77%); 0.82 ng/mL between T1D and LADA (sensitivity 82%, specificity 77%); and 1.65 ng/mL between T2D and MODY (sensitivity 72%, specificity 72%)., Conclusions: C-peptide is useful for the diagnostic differentiation of patients with type 1, type 2 diabetes, MODY, and LADA.
- Published
- 2024
- Full Text
- View/download PDF
22. A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients.
- Author
-
Vadillo E, Taniguchi-Ponciano K, Lopez-Macias C, Carvente-Garcia R, Mayani H, Ferat-Osorio E, Flores-Padilla G, Torres J, Gonzalez-Bonilla CR, Majluf A, Albarran-Sanchez A, Galan JC, Peña-Martínez E, Silva-Román G, Vela-Patiño S, Ferreira-Hermosillo A, Ramirez-Renteria C, Espinoza-Sanchez NA, Pelayo-Camacho R, Bonifaz L, Arriaga-Pizano L, Mata-Lozano C, Andonegui-Elguera S, Wacher N, Blanco-Favela F, De-Lira-Barraza R, Villanueva-Compean H, Esquivel-Pineda A, Ramírez-Montes-de-Oca R, Anda-Garay C, Noyola-García M, Guizar-García L, Cerbulo-Vazquez A, Zamudio-Meza H, Marrero-Rodríguez D, and Mercado M
- Subjects
- COVID-19 pathology, COVID-19 virology, Critical Illness, Humans, SARS-CoV-2 isolation & purification, COVID-19 blood, Myeloid Cells pathology
- Abstract
Background: SARS-CoV-2, the etiological agent causing COVID-19, has infected more than 27 million people with over 894000 deaths worldwide since its emergence in December 2019. Factors for severe diseases, such as diabetes, hypertension, and obesity have been identified however, the precise pathogenesis is poorly understood. To understand its pathophysiology and to develop effective therapeutic strategies, it is essential to define the prevailing immune cellular subsets., Methods: We performed whole circulating immune cells scRNAseq from five critically ill COVID-19 patients, trajectory and gene ontology analysis., Results: Immature myeloid populations, such as promyelocytes-myelocytes, metamyelocytes, band neutrophils, monocytoid precursors, and activated monocytes predominated. The trajectory with pseudotime analysis supported the finding of immature cell states. While the gene ontology showed myeloid cell activation in immune response, DNA and RNA processing, defense response to the virus, and response to type 1 interferon. Lymphoid lineage was scarce. Expression of genes such as C/EBPβ, IRF1and FOSL2 potentially suggests the induction of trained immunity., Conclusions: Our results uncover transcriptomic profiles related to immature myeloid lineages and suggest the potential induction of trained immunity., (Copyright © 2020 IMSS. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Inercia clínica en el tratamiento con insulina en el primer nivel de atención.
- Author
-
Vázquez F, Lavielle P, Gómez-Díaz R, and Wacher N
- Subjects
- Attitude of Health Personnel, Clinical Competence, Communication, Diabetes Mellitus, Type 2 drug therapy, Female, Humans, Male, Middle Aged, Quality of Health Care, Hypoglycemic Agents administration & dosage, Insulin administration & dosage, Physicians, Primary Care statistics & numerical data, Practice Patterns, Physicians' statistics & numerical data
- Abstract
Introduction: Refusal of physicians to prescribe insulin to their patients has been scarcely evaluated; the delay in treatment intensification hinders adequate and quality care., Objective: To identify the perception of primary care physicians about barriers to initiate insulin treatment in patients with diabetes., Method: Using the Smith Index and multivariate analysis, the relevance and grouping of concepts related to barriers to insulin prescription were assessed in 81 family doctors., Results: Only 35.8% of physicians showed confidence for prescribing insulin; almost half of them rated treatment intensification between moderately and little important (39.5% and 6.2%). Barriers were related to the physician (39.5%), the patient (37%), insulin treatment (11.1%) and the institution (6.2%); 6.2 % of physicians did not perceive any barrier. The barriers were grouped in 5 factors that explained 62.48% of the variance: patient cultural level, lack of medical skills, fear of adverse events, insecurity and lack of training., Conclusion: Clinical inertia was not the result of a complex medical condition or patient comorbidities, but of doctor's perception and confidence in his/her clinical and communication skills., (Copyright: © 2019 SecretarÍa de Salud.)
- Published
- 2019
- Full Text
- View/download PDF
24. Cross-tissue and tissue-specific eQTLs: partitioning the heritability of a complex trait.
- Author
-
Torres JM, Gamazon ER, Parra EJ, Below JE, Valladares-Salgado A, Wacher N, Cruz M, Hanis CL, and Cox NJ
- Subjects
- Adipose Tissue chemistry, Analysis of Variance, Body Mass Index, Genome-Wide Association Study statistics & numerical data, Humans, Linear Models, Mexican Americans genetics, Mexico, Muscle, Skeletal chemistry, Polymorphism, Single Nucleotide genetics, Principal Component Analysis, Texas, Diabetes Mellitus, Type 2 genetics, Phenotype, Quantitative Trait Loci genetics
- Abstract
Top signals from genome-wide association studies (GWASs) of type 2 diabetes (T2D) are enriched with expression quantitative trait loci (eQTLs) identified in skeletal muscle and adipose tissue. We therefore hypothesized that such eQTLs might account for a disproportionate share of the heritability estimated from all SNPs interrogated through GWASs. To test this hypothesis, we applied linear mixed models to the Wellcome Trust Case Control Consortium (WTCCC) T2D data set and to data sets representing Mexican Americans from Starr County, TX, and Mexicans from Mexico City. We estimated the proportion of phenotypic variance attributable to the additive effect of all variants interrogated in these GWASs, as well as a much smaller set of variants identified as eQTLs in human adipose tissue, skeletal muscle, and lymphoblastoid cell lines. The narrow-sense heritability explained by all interrogated SNPs in each of these data sets was substantially greater than the heritability accounted for by genome-wide-significant SNPs (∼10%); GWAS SNPs explained over 50% of phenotypic variance in the WTCCC, Starr County, and Mexico City data sets. The estimate of heritability attributable to cross-tissue eQTLs was greater in the WTCCC data set and among lean Hispanics, whereas adipose eQTLs significantly explained heritability among Hispanics with a body mass index ≥ 30. These results support an important role for regulatory variants in the genetic component of T2D susceptibility, particularly for eQTLs that elicit effects across insulin-responsive peripheral tissues., (Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
25. The predictors of glucose screening: the contribution of risk perception.
- Author
-
Lavielle P and Wacher N
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Interviews as Topic, Male, Mexico, Middle Aged, Risk Factors, Socioeconomic Factors, Attitude to Health, Blood Glucose analysis, Diabetes Mellitus, Type 2 prevention & control, Risk Reduction Behavior
- Abstract
Background: The prevention of type 2 diabetes is a challenge for health institutions. Periodic blood glucose screening in subjects at risk for developing diabetes may be necessary to implement preventive measures in patients prior to the manifestation of the disease and to efficiently diagnose diabetes. Not only medical aspects, but also psychological and social factors, such as the perception of risk (the individuals' judgment of the likelihood of experiencing an adverse event) influence healthy or preventive behaviors. It is still unknown if risk perception can have an effect on health behaviors aimed at reducing the risk of diabetes (glucose screening). The objective of study was to identify factors that influence glucose screening frequency., Methods: Eight hundred randomized interviews, which were stratified by socioeconomic level, were performed in Mexico City. We evaluated the perception of risk of developing diabetes, family history, health status and socioeconomic variables and their association with glucose screening frequency., Results: Of the study participants, 55.6% had not had their glucose levels measured in the last year, whereas 32.8% of the subjects reported having monitored their glucose levels one to three times per year and 11.5% had their levels monitored four or more times per year. Risk perception was significantly associated with the frequency of blood glucose screening. Having a first-degree relative with diabetes, being older than 45 years and belonging to a middle socioeconomic level increased the probability of subjects seeing a doctor for glucose screening., Conclusions: Glucose screening is a complex behavior that involves the subjects' perception of threat, defined as feeling vulnerable to the development of diabetes, which is determined by the subject's environment and his previous experience with diabetes.
- Published
- 2014
- Full Text
- View/download PDF
26. Association of β1 and β3 adrenergic receptors gene polymorphisms with insulin resistance and high lipid profiles related to type 2 diabetes and metabolic syndrome.
- Author
-
Burguete-Garcia AI, Martinez-Nava GA, Valladares-Salgado A, Bermudez Morales VH, Estrada-Velasco B, Wacher N, Peralta-Romero J, Garcia-Mena J, Parra E, and Cruz M
- Subjects
- Adult, Aged, Case-Control Studies, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 metabolism, Female, Gene Frequency, Humans, Male, Metabolic Syndrome epidemiology, Metabolic Syndrome metabolism, Mexico epidemiology, Middle Aged, Diabetes Mellitus, Type 2 genetics, Insulin Resistance genetics, Metabolic Syndrome genetics, Polymorphism, Genetic genetics, Receptors, Adrenergic, beta-1 genetics, Receptors, Adrenergic, beta-3 genetics
- Abstract
Background: Among the diverse genes associated to type 2 diabetes (T2D), the β-adrenergic receptors are an excellent candidate to study in Mexican population. The objective of this work was to analyze the association of polymorphisms in ADRB1 (rs1801253) (Arg389Gly) and ADRB3 (Trp64Arg) genes with T2D and metabolic syndrome (MS)., Methods: We studied 445 MS patients, 502 with T2D and 552 healthy controls. Anthropometric features and complete biochemical profile were evaluated, and Arg389Gly and Trp64Arg SNPs were determined by TaqMan assays. Data analysis was adjusted by African, Caucasian and Amerindian ancestral percentage., Results: The variant Arg389Gly of ADRB1 was statistically associated with an increase of LDL levels (P < 0.008), and the variant ADRB3 Trp64Arg was associated to larger HOMA-IR (P < 0.018) and with an increase of insulin levels (P < 0.001). A multiple logistic regression analysis was made in three grouping models: For ADRB3 in the codominant model Trp/Arg genotype, there was an OR of 1.53 (1.09-2.13, P < 0.003) which was increased up to OR 2.99 (1.44-6.22, P < 0.003) for the Arg/Arg genotype. Similar risk association was found under the dominant model Trp/Arg-Arg/Arg genotype with OR 1.67 (1.21-2.30; P < 0.002). In the recessive model (Arg/Arg genotype), there was also a high association OR 2.56 (1.24-5.26, P < 0.01)., Conclusions: The ADRB3 Trp64Arg variant is a susceptibility gene polymorphism for T2D and the ADRB1 Gly389Arg for lipid metabolism disruption. These results show that these variants are potential biomarkers for predicting metabolic alterations and evolution in diabetic and metabolic syndrome patients., (Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
27. Cardiovascular risk factors and acculturation in Yaquis and Tepehuanos Indians from Mexico.
- Author
-
Rodríguez-Morán M, Guerrero-Romero F, Brito-Zurita O, Rascón-Pacheco RA, Pérez-Fuentes R, Sánchez-Guillén MC, González-Ortiz M, Martínez-Abundis E, Simental-Mendía LE, Madero A, Revilla-Monsalve C, Flores-Martínez SE, Islas-Andrade S, Cruz M, Wacher N, and Sánchez-Corona J
- Subjects
- Adult, Aged, Cardiovascular Diseases blood, Cardiovascular Diseases physiopathology, Cholesterol, HDL blood, Diabetes Mellitus blood, Female, Humans, Hypertension physiopathology, Hypertriglyceridemia blood, Hypertriglyceridemia epidemiology, Male, Mexico epidemiology, Mexico ethnology, Middle Aged, Obesity epidemiology, Risk Factors, Cardiovascular Diseases epidemiology, Cardiovascular Diseases ethnology, Indians, North American
- Abstract
Background: Cardiovascular (CV) risk factors are influenced by behavioral, cultural, and social factors, suggesting that acculturation plays a significant role in the emergency and growth of chronic disease. The objective of this study was to determine the relation between CV risk factors and the main components of acculturation, in Yaquis and Tepehuanos Indians from Mexico., Methods: This was a cross-sectional population-based study in Yaquis and Tepehuanos communities from the Yaqui Valley in Sonora and the Sierra Madre Occidental Mountains in Durango, in northwest Mexico. Acculturation status is different in both ethnic groups, with Tepehuanos living in small and remote communities retaining their traditional lifestyle and Yaquis living in well-communicated communities that have assumed Westernized lifestyles., Results: A total of 278 indigenous (120 Tepehuanos and 158 Yaquis) were randomly enrolled. Prevalence of obesity (48.1 and 6.7%, p <0.001), diabetes (18.3 and 0.83%, p <0.001), hypertriglyceridemia (43.0 and 15.0%, p <0.001), alcohol consumption (46.8 and 26.6%, p >0.001), and smoking (29.7 and 15.0%, p = 0.006) were significantly higher in Yaquis Indians. High blood pressure (6.3 and 3.3%, p = 0.40) and low HDL-cholesterol (42.4 and 34.2%, p = 0.22) were similar between Yaquis and Tepehuanos. Multivariate regression analysis adjusted by sex and age showed a significant association between calorie intake from saturated fat, but not other nutrients of customary diet, with hyperglycemia (OR 7.4, 95% CI 2.6-20.1), hypertriglyceridemia (OR 3.1, 95% CI 1.5-6.3), and obesity (OR 3.4, 95% CI 1.6-10.1)., Conclusions: Among the components of acculturation, intake of saturated fat is the most strongly associated with the development of CV risk factors.
- Published
- 2008
- Full Text
- View/download PDF
28. Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors.
- Author
-
Martinez-Marignac VL, Valladares A, Cameron E, Chan A, Perera A, Globus-Goldberg R, Wacher N, Kumate J, McKeigue P, O'Donnell D, Shriver MD, Cruz M, and Parra EJ
- Subjects
- Africa, Western ethnology, Alleles, Base Sequence, Black People genetics, Case-Control Studies, Chromosome Mapping, Chromosomes, Human, Y genetics, DNA Primers genetics, DNA, Mitochondrial genetics, Female, Gene Flow, Gene Frequency, Genetic Markers, Genetic Predisposition to Disease, Humans, Indians, North American genetics, Male, Mexico, Models, Genetic, Risk Factors, White People genetics, Diabetes Mellitus, Type 2 genetics
- Abstract
Admixture mapping is a recently developed method for identifying genetic risk factors involved in complex traits or diseases showing prevalence differences between major continental groups. Type 2 diabetes (T2D) is at least twice as prevalent in Native American populations as in populations of European ancestry, so admixture mapping is well suited to study the genetic basis of this complex disease. We have characterized the admixture proportions in a sample of 286 unrelated T2D patients and 275 controls from Mexico City and we discuss the implications of the results for admixture mapping studies. Admixture proportions were estimated using 69 autosomal ancestry-informative markers (AIMs). Maternal and paternal contributions were estimated from geographically informative mtDNA and Y-specific polymorphisms. The average proportions of Native American, European and, West African admixture were estimated as 65, 30, and 5%, respectively. The contributions of Native American ancestors to maternal and paternal lineages were estimated as 90 and 40%, respectively. In a logistic model with higher educational status as dependent variable, the odds ratio for higher educational status associated with an increase from 0 to 1 in European admixture proportions was 9.4 (95%, credible interval 3.8-22.6). This association of socioeconomic status with individual admixture proportion shows that genetic stratification in this population is paralleled, and possibly maintained, by socioeconomic stratification. The effective number of generations back to unadmixed ancestors was 6.7 (95% CI 5.7-8.0), from which we can estimate that genome-wide admixture mapping will require typing about 1,400 evenly distributed AIMs to localize genes underlying disease risk between populations of European and Native American ancestry. Sample sizes of about 2,000 cases will be required to detect any locus that contributes an ancestry risk ratio of at least 1.5.
- Published
- 2007
- Full Text
- View/download PDF
29. Low adiponectin levels predict type 2 diabetes in Mexican children.
- Author
-
Cruz M, García-Macedo R, García-Valerio Y, Gutiérrez M, Medina-Navarro R, Duran G, Wacher N, and Kumate J
- Subjects
- Adiponectin, Body Mass Index, Child, Glucose Tolerance Test, Humans, Mexico epidemiology, Predictive Value of Tests, Reference Values, Diabetes Mellitus, Type 2 epidemiology, Intercellular Signaling Peptides and Proteins blood
- Published
- 2004
- Full Text
- View/download PDF
30. Relationship of insulin resistance and overweight with cortisol and dehydroepiandrosterone-sulfate levels.
- Author
-
Mino D, Amato D, Cuevas ML, Fonseca ME, Búrbano G, Wacher N, and Lifshitz A
- Subjects
- Adult, Age Factors, Blood Glucose analysis, Body Mass Index, Body Weight, Cholesterol blood, Female, Humans, Insulin blood, Male, Middle Aged, Regression Analysis, Sex Factors, Time Factors, Triglycerides blood, Dehydroepiandrosterone Sulfate blood, Hydrocortisone blood, Insulin Resistance, Obesity
- Abstract
Background: Our objective was to assess the relationship of hormones such as cortisol and dehydroepiandrosterone-sulfate (DHEA-S) with insulin resistance and overweight., Methods: We designed and conducted a cross-sectional, observational survey consisting of home visits within a previously defined area of Mexico City. The study included 303 apparently healthy volunteers from a middle-class socioeconomic urban community. We measured glucose, cholesterol, triglycerides, insulin, cortisol, and DHEA-S. Insulin resistance (IR) was defined as belonging to the first quartile of fasting glucose/insulin ratio (G/IR) distribution or fourth quartile of IR (HOMA). Overweight was defined as body mass index (BMI) > or =25 kg/m(2)., Results: To predict IR in women < or =35 years of age, principal component analysis (PCA) disclosed three components: 1) cholesterol, BMI, and diastolic blood pressure (DBP); 2) cholesterol, triglycerides, and cortisol, and 3) dehydroepiandrosterone-sulfate [DHEA-S]. Solely the latter (DHEA-S) was significantly associated with IR (odds ratio [OR] = 1.80, confidence interval 95% [CI 95%] 1.11-2.91, p = 0.015). For men < or =35 years of age, there were two components: 1) cholesterol, triglycerides, BMI, and DBP, and 2) DHEA-S, cholesterol, and cortisol. Component 1 was significantly associated with IR (OR = 5.65; CI 95% 1.62-19.65, p = 0.006). To predict overweight in women >35 years of age, there were three components, including 1) cholesterol and triglycerides, 2) cortisol, and 3) DHEA-S and G/IR. Component 2 was significantly associated with overweight (OR = 0.38, CI 95% 0.23-0.64, p = 0.000)., Conclusions: In women < or =35 years of age, high DHEA-S levels were associated with insulin resistance, which suggests that in young women DHEA-S exerts anti-estrogenic action, perhaps caused by its competitive binding with the estrogen receptor. Additionally, in women >35 years of age, low cortisol levels were associated with overweight. These associations were not identified for the male subgroup.
- Published
- 2002
- Full Text
- View/download PDF
31. Treatment of human immunodeficiency virus enteropathy with a gluten-free diet.
- Author
-
Nellen H, Flores G, and Wacher N
- Subjects
- Humans, Karnofsky Performance Status, Weight Gain, Diet, Glutens administration & dosage, HIV Enteropathy diet therapy
- Published
- 2000
- Full Text
- View/download PDF
32. [Modern clinical medicine].
- Author
-
Lifshitz A, Wacher NH, Halabe-Cherem J, and Jinich H
- Subjects
- Clinical Competence, Decision Making, Evidence-Based Medicine, Humans, Physician-Patient Relations, Clinical Medicine trends
- Published
- 1998
33. Changes in human serum antioxidant capacity and peroxidation after four months of exposure to air pollutants.
- Author
-
Medina-Navarro R, Lifshitz A, Wacher N, and Hicks JJ
- Subjects
- Adaptation, Physiological, Adult, Environmental Exposure, Humans, Mexico, Oxidation-Reduction, Oxidative Stress, Ozone pharmacology, Thiobarbituric Acid Reactive Substances analysis, Urban Health, Air Pollutants pharmacology, Lipid Peroxidation drug effects, Superoxide Dismutase blood
- Abstract
Twenty-one adult volunteers (aged 27-32 years), who had been living in Mexico City for four continuous months (physicians working as fellows) were studied the first and sixteenth week of their stay in order to learn the effects of the pollutants contained in Mexico City's atmosphere on some serum biochemical parameters. The activity of serum superoxide dismutase (SOD) decreased after 16 weeks in comparison with the values obtained the first week (109.6 to 56.9 mU/mg protein; 50% less). In contrast, the inhibitory capacity of serum vs. induced in vitro lipoperoxidation increased in relation to the length of stay (22%). The serum levels of thiobarbituric-reactive material also decreased in almost 30% (from 6.10 to 4.12 nmol). The other lipoperoxides measured were unchanged (chromolipids and diene conjugation). We propose that this may be as a result of the adaptative capacity of the human organism, within a pollutant atmosphere in which the ozone levels might participate in a decrease of SOD activity during chronic exposure, to air pollution.
- Published
- 1997
34. Effects of pentoxifylline in patients with septic shock.
- Author
-
Castanón-González JA, Eid-Lidt G, Wacher N, Gallegos-Pérez H, and Miranda-Ruíz R
- Subjects
- Humans, Middle Aged, Shock, Septic physiopathology, Oxygen Consumption drug effects, Pentoxifylline pharmacology, Pentoxifylline therapeutic use, Shock, Septic drug therapy
- Published
- 1997
- Full Text
- View/download PDF
35. Predictive value of signs and symptoms in the diagnosis of subarachnoid hemorrhage among stroke patients.
- Author
-
Talavera JO, Wacher NH, Laredo F, Halabe J, Rosales V, Madrazo I, and Lifshitz A
- Subjects
- Adolescent, Adult, Age Factors, Aged, Cerebral Hemorrhage diagnosis, Cerebral Infarction diagnosis, Diagnosis, Differential, Female, Humans, Male, Mexico epidemiology, Middle Aged, Neck Muscles physiopathology, Neurologic Examination, Observer Variation, Odds Ratio, Predictive Value of Tests, ROC Curve, Referral and Consultation, Regression Analysis, Retrospective Studies, Seizures etiology, Sensitivity and Specificity, Subarachnoid Hemorrhage epidemiology, Physical Examination, Subarachnoid Hemorrhage diagnosis
- Abstract
Clinical diagnosis of subarachnoid hemorrhage (SAH) is frequently misdiagnosed with intracerebral hemorrhage (ICH) or cerebral infarction (CI), which delays appropriate referral. This study was undertaken to create a clinical index to select, among stroke patients, those with the highest probability of having a SAH. Clinical data of patients with acute stroke were evaluated with the X2 and the Fisher exact test; a p value < 0.05 was considered significant. Significant variables were included in a "log-lineal regression analysis" where those with an odds ratio (OR) 95% confidence limits not including the unit were considered to construct an index using the odds ratio coefficient (C). The results indicated that of 197 records which were included, 22 cases of SAH and 175 of ICH or CI were demonstrated. Kappa coefficients for observer variation in clinical data retrieval was 0.91. After "log-lineal regression analysis" was carried out the following variables were significant: neck stiffness (C = 3, OR = 21); lack of focal neurologic signs (C = 2, OR = 6.88); and age < or = 60 years (C = 1.5, OR = 4.35). A fourth variable, seizures (C = 1, OR = 3.25), was marginally significant (p = 0.07), but added predictive value to the index. The positive predictive values of the sum of the coefficients were: 0 = 0%; 1-2 = 3%; 2.5-3.5 = 21%; 4-5 = 40%; 6.5 = 75%; 7.5 = 100%. In conclusion, when a stroke patient shows neck stiffness, or any combination of young age, lack of focal neurologic signs or seizures (a score > or = 2.5, the index has a 91% sensitivity and 82% specificity), he/she must be referred to a tertiary care center.
- Published
- 1996
36. Circadian variation of human acute phase response.
- Author
-
Perdiz P, Wacher N, Laredo-Sánchez F, Halabe Cherem J, and Lifshitz A
- Subjects
- Humans, Acute-Phase Reaction, Circadian Rhythm physiology
- Abstract
Circadian variation of temperature, both normal and febrile, is a well known fact. Mediators of fever are also regulators of acute phase response and are associated with stimulation of pituitary hormone production related with defervescence and with a circadian pattern of secretion. Acute phase response may consequently have circadian variations in its components. Measurements of temperature, erythrocyte sedimentation rate, complete blood cell count, serum cortisol and fibrinogen were made at 7:00, 15:00, and 23:00 h during two consecutive days in 35 patients with fever and acute infection, 15 patients with clinically active ankylosing spondylitis without fever and 10 healthy volunteers. Temperature curves showed statistically significant circadian rhythms, with higher values at night and lower ones during early morning. Erythrocyte sedimentation rate, leukocyte count and fibrinogen also showed statistically significant circadian rhythms, but with higher values at 15:00 h. Serum cortisol also showed statistically significant circadian rhythmicity but with a higher rhythm adjusted mean (MESOR), and a 100 degrees (6 h) phase shift in patients with fever, as compared to patients with ankylosing spondylitis and healthy controls. In conclusion, components of acute phase response, including fever, have circadian rhythmicity, but asynchronically. Differences between fever and ankylosing spondylitis can be due to the intensity of acute phase response stimulation.
- Published
- 1996
37. Possible effect of air pollutants (Mexico City) on superoxide dismutase activity and serum lipoperoxides in the human adult.
- Author
-
Hicks JJ, Medina-Navarro R, Guzman-Grenfell A, Wacher N, and Lifshitz A
- Subjects
- Adult, Humans, Mexico, Air Pollutants adverse effects, Lipid Peroxides blood, Superoxide Dismutase metabolism
- Abstract
The action of air pollutants, through their constituents, (O3, NO2, tobacco smoke) are capable of causing damage due to their lipoperoxidative properties or, indirectly, by inducing production of free radicals. As a consequence of photochemical processes, the ozone levels in the atmosphere of Mexico City are generally higher (mean of 0.325 ppm; period between 1987-1992) and may be harmful to health. Sixty two volunteers (medical doctors), aged 27-32 years, were divided into three groups. Group A was composed of those persons (17) who had never lived in Mexico City; a second group (B) (21) had recently arrived in Mexico City (1-8 days); and a third group (C) (24) who had permanently resided in Mexico City. Serum was obtained from fresh whole blood. Superoxide dismutase (SOD) activity and thiobarbituric acid-reactive materials were higher in group B while chromolipids and the serum inhibitory capacity (for lipoperoxidation) was higher in group C. The acute exposure to pollutants in group B apparently may have induced SOD as an antioxidant defense and was responsible for the increased level of TBA reactive material. In group C, the significant finding is better antioxidative defenses and slightly higher chromolipids.
- Published
- 1996
38. An assessment of cerebrospinal fluid's total creatine-kinase activity in the differential diagnosis of metabolic and organic causes of coma.
- Author
-
Galindo L, Fiorelli S, Wacher NH, Ríos S, Laredo F, Halabe J, Zavala Villagómez B, Alvarez H, and Lifshitz A
- Subjects
- Adult, Aged, Coma enzymology, Coma etiology, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Coma cerebrospinal fluid, Creatine Kinase cerebrospinal fluid
- Abstract
The objective of the study was to assess total cerebrospinal creatinine-kinase activity (CSF-CK) measurement in differential diagnosis of "metabolic" and organic causes of coma. The setting for the study was a tertiary care reference medical center and community general hospital. The design of the study was a series of consecutive patients with profound coma (Glasgow scale ratings between 3 and 6) as the presenting complaint to the emergency room and controls. Measurements and main results were as follows: CSF-CK was measured in 103 consecutive patients including 18 patients with metabolic causes of coma, 27 patients with organic causes of coma, 18 patients scheduled for elective orthopedic surgery with epidural anesthesia and 27 patients with compressive myelopathy and radiculopathy. CSF-CK activities were significantly different between groups (H = 29.48, p < 0.001, Kruskal-Wallis test), controls had a median of 0 mU/ml (range 0-16 mU/ml), patients with metabolic causes of coma had a median of 0 mU/ml (range 0-65 mU/ml), patients with compressive myelopathy or radiculopathy had a median of 19 mU/ml (range 0-80 mU/ml), and patients with organic causes of coma had a median of 20 mU/ml (range 0-400 mU/ml). The test sensitivity was 83% (95% confidence interval (CI 65-100%) specificity 62% (CI 43-80%) positive predictive value 60% (CI 49-79%) and negative predictive value 85% (CI 75-95%). The conclusion of the study was that the test is useful for ruling out metabolic causes of coma when CSF-CK activity is high (i.e., above 16 mU/ml).
- Published
- 1995
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.